Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Boehringer Ingelheim
QuintilesIMS
AstraZeneca
Harvard Business School
Colorcon
Mallinckrodt
Daiichi Sankyo
Medtronic
Fuji

Generated: August 21, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Aromatic ketones and processes for their preparation
Abstract:The present invention relates to substantially pure piperidine derivative compounds of the formulae: ##STR1## wherein R.sub.1 is hydrogen or hydroxy; R.sub.2 is hydrogen; or R.sub.2 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2 ; R.sub.3 is --COOH or --COOR.sub.4 ; R.sub.4 has 1 to 6 carbon atoms; A, B, and D are the substituents of their respective rings each of which may be different or the same and are hydrogen, halogens, alkyl, hydroxy, alkoxy, or other substituents. A process of preparing such piperidine derivative compounds in substantially pure form is also disclosed.
Inventor(s): D'Ambra; Thomas E. (Wynantskill, NY)
Assignee: Albany Molecular Research, Inc. (Albany, NY)
Filing Date:May 31, 1995
Application Number:08/455,991
Claims:1. A compound of the formula: ##STR42## wherein R.sub.3 is --COOH or --COOR.sub.4 ;

R.sub.4 is an alkyl with 1 to 6 carbon atoms;

A is the substituents of its ring, each of which may be different or the same, and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy or alkoxy.

2. A compound according to claim 1, wherein the compound is a substantially pure regioisomer.

3. A salt having the formula: ##STR43## wherein X.sup.+ is a Lewis acid;

A is the substituents of its ring, each of which may be different or the same, and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy or alkoxy.

4. A salt according to claim 2, wherein the salt is a substantially pure regioisomer.

5. A process of preparing a substantially pure regioisomer of the formula: ##STR44## wherein R.sub.3 is --COOH or --COOR.sub.4 ;

R.sub.4 is an alkyl with 1 to 6 carbon atoms;

A is the substituents of its ring, each of which may be different or the same, and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy or alkoxy

said process comprising:

providing a second mixture of regioisomers of the formula: ##STR45## recovering from the second mixture of regioisomers the substantially pure regioisomer.

6. A process according to claim 5, wherein said recovering comprises:

crystallizing from the second mixture of regioisomers a substantially pure regioisomer salt of the formula: ##STR46## wherein X.sup.+ is a Lewis acid; isolating the substantially pure regioisomer salt; and

converting the substantially pure regioisomer salt to the substantially pure regioisomer of the formula: ##STR47##

7. A process according to claim 5, wherein X.sup.+ is an alkali metal salt or an ammonium salt of the form NR.sub.7 R.sub.8 R.sub.9 wherein R.sub.7, R.sub.8, and R.sub.9 are individually hydrogen or a straight or branched alkyl of 1 to 6 carbon atoms, or an alkyl substituted at any position with a phenyl ring or a substituted phenyl ring.

8. A process according to claim 7, wherein X.sup.+ is cinchonidine and A is hydrogen.

9. A process according to claim 5, wherein said providing the second mixture of regioisomers comprises:

acylating a starting compound of the formula: ##STR48## wherein R.sub.5 is --OR.sub.6, --N(R.sub.6).sub.2, and --SR.sub.6, and

R.sub.6 is an alkyl with 1 to 6 carbons,

with a compound of the formula: ##STR49## wherein X is a halogen,

under conditions effective to produce a first mixture of regioisomers of the formula: ##STR50## hydrolyzing the first mixture of regioisomers under conditions effective to form the second mixture of regioisomers of the formula: ##STR51##

10. A process according to claim 9, wherein said acylating is carried out by a Friedel-Crafts reaction using an AlCl.sub.3 catalyst.

11. A process according to claim 5, wherein said providing the second mixture of regioisomers comprises

acylating a starting compound of the formula: ##STR52## wherein R.sub.5 is --OR.sub.6, --N(R.sub.6).sub.2, and --SR.sub.6, and

R.sub.6 is an alkyl with 1 to 6 carbon atoms with a compound of the formula: ##STR53## under conditions effective to produce a first mixture of regioisomers of the formula: ##STR54## hydrolyzing the first mixture of regioisomers under conditions effective to form a second mixture of regioisomers of the formula: ##STR55##

12. A process according to claim 11, wherein said recovering comprises:

crystallizing from the second mixture of regioisomers a substantially pure regioisomer salt of the formula: ##STR56## wherein X.sup.+ is a Lewis acid; isolating the substantially pure regioisomer salt; and

converting the substantially pure regioisomer salt to the substantially pure regioisomer of the formula: ##STR57##

13. A process according to claim 12, wherein X.sup.+ is an alkali metal salt or an ammonium salt of the form NR.sub.7 R.sub.8 R.sub.9 wherein R.sub.7, R.sub.8, and R.sub.9 are individually hydrogen or a straight or branched alkyl of 1 to 6 carbon atoms, or an alkyl substituted at any position with a phenyl ring or a substituted phenyl ring.

14. A process according to claim 13, wherein X.sup.+ is cinchonidine and A is hydrogen.

15. A process of preparing a second substantially pure regioisomer of the formula: ##STR58## wherein X is a halogen;

R.sub.3 is a --COOH or --COOR.sub.4 ;

R.sub.4 is an alkyl with 1 to 6 carbon atoms;

A is the substituents of its ring, each of which may be different or the same, and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy or alkoxy

said process comprising:

providing a first substantially pure regioisomer of the formula: ##STR59## and halogenating the first substantially pure regioisomer under conditions effective to form the second substantially pure regioisomer.

16. A process of preparing a substantially pure regioisomer of the formula: ##STR60## wherein R.sub.3 is --COOH or --COOR.sub.4

R.sub.4 is an alkyl with 1 to 6 carbon atoms;

A is the substituents of its ring, each of which may be different or the same, and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxyl or alkoxy

said process comprising:

acylating a starting compound of the formula: ##STR61## with a compound of the formula: ##STR62## wherein X.sub.1 is a halogen, trialkyl tin, triflate, or substituents useful in organometalic coupling reactions under conditions effective to produce the substantially pure regioisomer.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
QuintilesIMS
Fuji
Queensland Health
Merck
US Army
Johnson and Johnson
Julphar
UBS
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot